JTCS Medtronic Endurant
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Potapov, E.V.
Right arrow Articles by Hetzer, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Potapov, E.V.
Right arrow Articles by Hetzer, R.
Related Collections
Right arrow Mechanical Circulatory Assistance
Right arrow Transplantation - heart

J Thorac Cardiovasc Surg 2005;130:930
© 2005 The American Association for Thoracic Surgery

Brief Communication

Bridging to transplantability with a ventricular assist device

E.V. Potapov, MD * , Y. Weng, MD, PhD, M. Jurmann, MD, H. Lehmkuhl, MD, R. Hetzer, MD, PhD

Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum, Berlin, Germany.

Received for publication April 14, 2005; accepted for publication April 28, 2005.

* Address for reprints: Evgenij V. Potapov, MD, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, 13353 Berlin, Germany (Email: potapov@dhzb.de).

The first 20% of the full text of this article appears below.

The implantation of a ventricular assist device (VAD) is an accepted option in patients with end-stage heart failure. However, the durability of these devices is limited to a number of years, and complications still limit outcome. In children and young adults with end-stage heart failure and contraindications for heart transplantation, there are thus no long-term options available.

Clinical Summary

A 15-year-old girl had osteosarcoma of the left femur, which was radically operated on in December 2001. The patient received postoperative chemotherapy with doxorubicin and cisplatin for 5 months. In May 2002, cardiomyopathy developed, subsequently leading to biventricular heart failure. The patient's condition deteriorated rapidly, . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
 Eur J Cardiothorac SurgHome page
E. Mikus, A. Stepanenko, T. Krabatsch, A. Loforte, M. Dandel, H. B. Lehmkuhl, R. Hetzer, and E. V. Potapov
Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients
Eur J Cardiothorac Surg, October 1, 2011; 40(4): 971 - 977.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
R. Hetzer, E. V. Potapov, V. Alexi-Meskishvili, Y. Weng, O. Miera, F. Berger, E. Hennig, and M. Hubler
Single-center experience with treatment of cardiogenic shock in children by pediatric ventricular assist devices.
J. Thorac. Cardiovasc. Surg., March 1, 2011; 141(3): 616 - 623.e1.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Cardiothorac SurgHome page
E. Mikus, A. Stepanenko, T. Krabatsch, M. Dandel, H. B. Lehmkuhl, A. Loforte, R. Hetzer, and E. V. Potapov
Left ventricular assist device or heart transplantation: impact of transpulmonary gradient and pulmonary vascular resistance on decision making
Eur J Cardiothorac Surg, March 1, 2011; 39(3): 310 - 316.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
E. V. Potapov, M. J. Jurmann, T. Drews, M. Pasic, M. Loebe, Y. Weng, and R. Hetzer
Patients supported for over 4 years with left ventricular assist devices
Eur J Heart Fail, November 1, 2006; 8(7): 756 - 759.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by The American Association for Thoracic Surgery.